Navigation Links
Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on BELLUS Health Inc.

NEW YORK, Jan. 13 /PRNewswire/ -- Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview(R) (EIO(R)) on BELLUS Health Inc. (BLU: TSX). The full 52-page report can be found at

BELLUS Health Inc. ("BELLUS Health" or "the Company") is a global health company focused on providing innovative pharmaceutical and nutraceutical solutions for critical unmet needs. BELLUS Health aims to generate revenue in the short to medium term through the marketing and sale of branded nutraceutical products, thus enabling the medium- to long-term development and commercialization of its pharmaceutical pipeline. The Company's pharmaceutical products target disorders with no known cures and limited treatments. BELLUS Health's most advanced pharmaceutical candidate is KIACTA(TM) (eprodisate), a Phase III compound to treat Amyloid A (AA) amyloidosis, a disease marked by an accumulation of abnormal proteins that can lead to organ failure and death. In a Phase II/III trial of eprodisate, patients on KIACTA(TM) (eprodisate) had a lower risk of progression of AA amyloidosis-related renal disease and a slower rate of decline in creatinine clearance (a reduction in clearance indicates worsened renal disease). BELLUS Health expects to file a new protocol amendment to the Investigational New Drug (IND) application for the second pivotal Phase III clinical trial of KIACTA(TM) in the first quarter 2009.

The Company's other pharmaceutical developments include NC-503 (eprodisate), which is currently in a proof-of-concept Phase II study in patients with Type II diabetes and certain features of metabolic syndrome, and a prodrug program for Alzheimer's disease (AD), which is at the preclinical development stage. The Company, through its wholly owned subsidiary, OVOS Natural Health Inc., is also commercializing a condition-specific, clinically tested branded nutraceutical to protect memory. This first product, VIVIMIND(TM), was launched in Canada in September 2008 and is also available via the Internet. The Company plans to market VIVIMIND(TM) in the U.S. in 2009 and in the EU in 2011.

About Crystal Research Associates, LLC

Crystal Research Associates, LLC is an independent research firm that provides institutional-quality, fee-based research to small and mid-cap companies. Crystal Research Associates' unique and novel product, the Executive Informational Overview(R) (EIO(R)), is free of investment ratings, target prices, and forward-looking financial models. The EIO(R) presents a crystal clear, detailed report on a company (public or private) in a manner that is easily understood by the Wall Street financial community. The EIO(R) details a company's product/technology/service offerings, market size(s), key intellectual property, leadership, growth strategy, competition, risks, financial statements, key events, and other such fundamental information. Crystal Research Associates has offices in New York City, Delray Beach, Montreal, and Toronto. Crystal Research Associates has been compensated by the Company in cash of fifty thousand U.S. dollars for its services in creating this report, for updates, and for printing costs.

Forward-Looking Safe Harbor Statement

Statements in this news release regarding future financial and operating results, potential applications of the Company's technology, opportunities for the Company, and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed may constitute forward-looking statements as defined by applicable securities legislation. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements including, limited operating history, need for future capital, and economic conditions generally. Additional information on potential factors that could affect results and other risks and uncertainties are detailed from time to time in the Company's periodic reports, including forms filed with the SEC or SEDAR.

These statements and other forward-looking statements involve numerous risks and uncertainties, known and unknown. Consequently, actual future results may differ materially from the anticipated results expressed in the forward-looking statements. Crystal Research Associates assumes no obligation to update any of the forward-looking statements in this release.

SOURCE Crystal Research Associates, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Unilife Medical Solutions Limited
2. Crystallography reveals the 3-D structure of mammalian sperm receptor
3. Asia Wellness Cruise Offers Crystal Guests Peace of Mind, Body & Spirit
4. Crystalens HD(TM) Receives FDA Approval
5. Success for Crystal Meth Drug Addict on YouTube
6. Steve and Paula Mae Schwartz Honored With Publicity Club of New Englands Crystal Bell Award
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on BioCurex, Inc.
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Advaxis, Inc.
9. Measurement technique probes surface structure of gold nanocrystals
10. Crystal Light and Mandy Moore Launch Unique Online Wellness Community for Women
11. Wellness Experts From Cleveland Clinic Set for 2008 Crystal Voyages
Post Your Comments:
(Date:11/30/2015)... ... 2015 , ... TransPack Volume 6 features 30 customizable transitions created exclusively for ... to wipes with blur & drop shadow options. Utilize the controls in the ... clip to the next with TransPack's easily customizable styles. , TransPack Volume ...
(Date:11/30/2015)... ... November 30, 2015 , ... Workstation ... more than 30 HealthPostures’ dealers located throughout the United States, is OneStop Ergonomics. ... of corporate, industrial, manufacturing and government workers and organizational leaders that are introduced ...
(Date:11/29/2015)... Petersburg, FL (PRWEB) , ... November 30, 2015 ... ... are available today from the new company, Sublime Beauty NATURALS®. All products are ... and natural products, like essential oils, organic facial serums and USDA Certified Organic ...
(Date:11/29/2015)... ... November 29, 2015 , ... Khanna Vision Institute based in Los Angeles, announced ... November 25th 2015. Peer Certification by the Board is done so the public knows ... is first obtained after the completion of three years of training or Residency in ...
(Date:11/29/2015)... ... November 29, 2015 , ... Key Housing, a top-rated corporate housing service for ... featured apartment community: Epic. In showcasing this featured apartment community in San Jose, Key ... rental market to efficiently find housing suitable to their needs by showcasing quality housing. ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... , November 30, 2015 Mexico Healthcare ... and Life Sciences Report 2015 . --> Pharmaboardroom releases ... . Latin America , a country of ... , a country of over 122 million people. --> ... healthcare, pharmaceuticals, or life sciences insights into the second largest pharma ...
(Date:11/29/2015)... AMSTERDAM , Nov. 29, 2015   Royal ... data driven radiology solutions at the 2015 Radiological Society ... December 4 at McCormick Place in Chicago ... will experience the company,s broad portfolio of integrated ... Management solutions to increase clinical performance, improve workflow and ...
(Date:11/27/2015)... , Pays-Bas, November 27, 2015 ... au traitement photodynamique au Bremachlorin contre le cancer ... approche consistant à combiner l,immunothérapie au traitement photodynamique ... --> Une nouvelle approche consistant ... contre le cancer avancé.    ...
Breaking Medicine Technology: